![Marc Hedrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 163 420 $ al 31/05/2026
Marc H.
Hedrick was the founder of StemSource, Inc., founded in 2000, where the titles held included President, Chief Executive Officer & Director from 2001 to 2003.
Dr. Hedrick currently holds the positions of President, Chief Executive Officer & Director at Plus Therapeutics, Inc. since 2019.
Former jobs include President, Chief Executive Officer & Director at Cytori Therapeutics, Inc. (JP); Chief Scientific Officer & Medical Director at MacroPore Biosurgery, Inc. from 2002 to 2004; Co-Director at UCLA Anderson School of Management; Director at Cytori Ltd.; and Associate Professor at the University of California, Los Angeles.
Education includes a doctorate from The University of Texas Southwestern Medical Center conferred in 1988 and an MBA from UCLA Anderson School of Management conferred in 2005.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PLUS THERAPEUTICS, INC. 0,41 % | 14/05/2026 | 28.044 ( 0,41 % ) | 163 216 $ | 31/05/2026 |
| 25/07/2018 | 35 ( -.--% ) | 204 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Director Ejecutivo | 02/04/2014 |
| Empresas | Cargo | Fin |
|---|---|---|
MacroPore Biosurgery, Inc. /Old/
 MacroPore Biosurgery, Inc. /Old/ Medical SpecialtiesHealth Technology Manufactures biocompatible surgical implants for the reconstruction and regeneration of bones | Director Técnico/Científico/I+D | 01/01/2004 |
StemSource, Inc.
 StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatements to cancer | Fundador | 01/01/2003 |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cytori Therapeutics, Inc. (JP)
 Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Provides cell therapy treatments and services | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
MacroPore Biosurgery, Inc. /Old/
MacroPore Biosurgery, Inc. /Old/ Medical SpecialtiesHealth Technology Manufactures biocompatible surgical implants for the reconstruction and regeneration of bones | Health Technology |
StemSource, Inc.
StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatements to cancer | Commercial Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytori Ltd.
 Cytori Ltd. Pharmaceuticals: OtherHealth Technology Develops biological products | Health Technology |
Cytori Therapeutics, Inc. (JP)
Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Provides cell therapy treatments and services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
